In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia

Blood

Volumn 124, Issue 20, 2014, Pages 3172-3174

  Augustsson, Cecilia ^a   Persson, Egon ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; ENZYME PRECURSOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOPLASTIN; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEMOPHILIA; HUMAN; HUMAN CELL; IN VITRO STUDY; BLOOD; HEMOPHILIA A; METABOLISM;

COAGULANTS; FACTOR VII; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HUMANS; RECOMBINANT PROTEINS; THROMBIN; THROMBOPLASTIN;

EID: 84911456736     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-576892     Document Type: Article

References (17)

1. Persson E, Bolt G, Steenstrup TD, Ezban M. Recombinant coagulation factor VIIa-from molecular to clinical aspects of a versatile haemostatic agent. Thromb Res. 2010;125(6):483-489.
2. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood. 2004;104(13):3858-3864.
3. van 't Veer C, Golden NJ, Mann KG. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood. 2000;95(4):1330-1335.
4. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. 2002;99(3):923-930.
5. Hoffman M, Monroe DM, Roberts HR. Plateletdependent action of high-dose factor VIIa. Blood. 2002;100(1):364-365, author reply 365.
6. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997;99(3):542-547.
7. Shibeko AM, Woodle SA, Lee TK, Ovanesov MV. Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood. 2012;120(4):891-899.
8. Feng D, Whinna H, Monroe D, Stafford DW. FVIIa as used pharmacologically is not TF dependent in hemophilia B mice. Blood. 2014;123(11):1764-1766.
9. Persson E, Olsen OH. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa. FEBS J. 2009;276(11):3099-3109.
10. McNicol A. Platelet preparation and estimation of functional responses. In: Watson SP, Authi KS, eds. Platelets: A Practical Approach. Oxford, UK: IRL Press at Oxford University Press; 1996:1-26.
11. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33(1):4-15.
12. Kelley RF, Yang J, Eigenbrot C, et al. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity. Biochemistry. 2004;43(5):1223-1229.
13. Radcliffe R, Nemerson Y. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975;250(2):388-395.
14. Rao LV, Rapaport SI, Bajaj SP. Activation of human factor VII in the initiation of tissue factordependent coagulation. Blood. 1986;68(3):685-691.
15. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest. 1979;64(4):1056-1065.
16. Yamamoto M, Nakagaki T, Kisiel W. Tissue factor-dependent autoactivation of human blood coagulation factor VII. J Biol Chem. 1992;267(27):19089-19094.
17. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogencofactor complexes. Implications of a twodimensional enzyme kinetic mechanism. J Biol Chem. 1993;268(29):21489-21492.